Myovant Sciences Ltd. Retained Earnings
Myovant Sciences Ltd. had Retained Earnings of -$1.38 billion as of 2022-12-31, per its 10-Q filed 2023-01-26.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2023-01-26
- 2022-12-31: Retained Earnings (Accumulated Deficit) -$1.38B.
- 2022-09-30: Retained Earnings (Accumulated Deficit) -$1.32B.
- 2022-06-30: Retained Earnings (Accumulated Deficit) -$1.27B.
- 2022-03-31: Retained Earnings (Accumulated Deficit) -$1.25B.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2022-12-31 | -$1.38B 10-Q · filed 2023-01-26 |
| 2022-09-30 | -$1.32B 10-Q · filed 2022-10-26 |
| 2022-06-30 | -$1.27B 10-Q · filed 2022-07-27 |
| 2022-03-31 | -$1.25B 10-Q · filed 2023-01-26 |
| 2021-12-31 | -$1.19B 10-Q · filed 2022-01-26 |
| 2021-09-30 | -$1.13B 10-Q · filed 2021-10-26 |
| 2021-06-30 | -$1.11B 10-Q · filed 2021-07-28 |
| 2021-03-31 | -$1.05B 10-K · filed 2022-05-11 |
| 2020-12-31 | -$964.78M 10-Q · filed 2021-02-11 |
| 2020-09-30 | -$890.94M 10-Q · filed 2020-11-12 |
| 2020-06-30 | -$823.87M 10-Q · filed 2020-08-11 |
| 2020-03-31 | -$791.01M 10-K · filed 2021-05-11 |
| 2019-12-31 | -$726.10M 10-Q · filed 2020-02-10 |
| 2019-09-30 | -$640.50M 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$569.93M 10-Q · filed 2019-08-06 |
| 2019-03-31 | -$502.02M 10-K · filed 2020-05-18 |
| 2018-12-31 | -$427.01M 10-Q · filed 2019-02-07 |
| 2018-09-30 | -$356.38M 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$290.61M 10-Q · filed 2018-08-07 |
| 2018-03-31 | -$228.47M 10-K · filed 2019-05-24 |
| 2017-12-31 | -$180.22M 10-Q · filed 2018-02-13 |
| 2017-09-30 | -$138.44M 10-Q · filed 2017-11-13 |
| 2017-06-30 | -$108.54M 10-Q · filed 2017-08-10 |
| 2017-03-31 | -$85.10M 10-K · filed 2018-06-07 |
| 2016-12-31 | -$63.42M 10-Q · filed 2017-02-13 |
| 2016-09-30 | -$55.34M 10-Q · filed 2016-12-09 |
| 2016-03-31 | -$1.66M 10-K · filed 2017-06-14 |